SAFC at ESACT 2011

Published: 27-Jun-2011
Pharmaceutical

Dynamic presentations now available to be viewed online


SAFC recently attended ESACT 2011 where the company presented workshops and scientific posters that addressed issues the biopharmaceutical industry is facing in today’s market and the innovative solutions SAFC can provide.

Topics included:

  • Risk Management in Biopharmaceutical Manufacturing
  • SAFC’s New Zinc Finger Nuclease CHOZN Cell Line Technology
  • Sartorius Stedim Biotech Partnership with SAFC

These dynamic presentations can now be viewed here.

  • Companies:
  • Merck Electronics KGaA
See more

You may also like

Design & Build

Merck ups single-use product assembly with $30m expansion in France

Read more
The investment in Molsheim will add 1,700 sqm of ISO Class 7 or ISO Class 5 cleanrooms, using modular building design and existing infrastructure to allow future expansions without any disruptions

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. The colouration of tablets and capsules Paul Smith from Sensient Pharmaceutical Technologies discusses the use of colour in solid oral dosage forms
  3. Production of pharmaceutical compounds through microbial fermentation Most people’s experience of fermentation will be through its most famous and popular use – the brewing of beer
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
  5. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Design & Build

Merck ups single-use product assembly with $30m expansion in France

The investment in Molsheim will add 1,700 sqm of ISO Class 7 or ISO Class 5 cleanrooms, using modular building design and existing infrastructure to allow future expansions without any disruptions
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Research & Development

Merck announces VAR2 Pharmaceuticals as winner of its advance biotech grant

The company was selected for its development of a drug-conjugated malaria protein
Manufacturing

Is the technology ready for perfusion processes?

Read our white paper to learn more about the use of a cell retention device and specially designed expansion media
Manufacturing

Merck invests $109m in viral vector and gene therapy manufacturing

German Merck has announced a second Carlsbad, California facility to double its BioReliance viral and gene therapy service offering
Research & Development

New technology in cell and gene therapies to meet patient needs

Angela Myers, Head of Gene Editing and Novel Modalities at Merck, outlines the challenges arising with the increasing demand for safe and efficacious treatments and new technology development to improve and standardise the manufacturing process
Manufacturing

CPhI Pharma Awards winners

Top innovators, performers and outstanding achievements have been recognised by global industry event
Subscribe now